New Collaboration Links Diabetes eHealth and Medical Call-Center Operator Services in Nordic Region

Diabetes ToolsDiabetes Tools, Swedish medtech developer of the TriabetesClinic app-based decision support service, and MedHelp, northern Europe's largest privately owned healthcare advisory service, jointly announce a cooperation that offers greater access to specialist medical advice for diabetes patients across the Nordic region.

The two companies will promote each other's services to healthcare providers in Denmark, Finland, Norway and Sweden, in addition to offering combined services. For example, treatment clinics that care for insulin-dependent children and buy Diabetes Tools' pediatric service can offer parents of their young patients round-the-clock monitoring and support by telephone and video from MedHelp's established medical call-center services.

"Our goal is to ensure that everyone living with diabetes gets the best possible care in the most user-friendly way," said Diabetes Tools' Chief Executive Officer Anders Weilandt. "Working with MedHelp means that together we can now fulfil an everyday need by giving each Triabetes-connected patient round-the-clock service from MedHelp's diabetes specialists who use TriabetesClinic as a tool. As a result, patients will have peace of mind about their health and forward-thinking healthcare providers will see greater opportunities to improve care quality, health outcomes and economic productivity."

"We work with hospitals, municipalities and regions to give cost-effective medical support to patients over the phone," said CEO of MedHelp Andreas Winqvist. "It is natural to take the next step, from advice over the phone to digitalized care. Diabetes nurses are already part of our advisory teams and now following today's agreement with Diabetes Tools, many more people can benefit from their professional expertise."

The collaboration between Diabetes Tools and MedHelp may be expanded with additional products and territories in the future.

Both companies are attending the Vitalis 2016 congress for the Scandinavian eHealth industry in Göteborg, Sweden from 5-7 April (exhibition stands B08:31 for Diabetes Tools and B08:05 for MedHelp).

About Diabetes Tools
Diabetes Tools is a Swedish medical technology company that simplifies daily life for everyone involved in diabetes care. The TriabetesClinic software service securely combines apps (for smartphones and tablets), online accounts and web interfaces to change diabetes healthcare for the better.

Diabetes Tools was nominated for "Best Mobile Innovation for Health" at the 2016 Global Mobile Awards and named "MedTech Company of the Year 2014" by the Swedish Medtech Association. The company holds an ISO 13485 certificate, a compliance standard for creating medical devices and related services, and sells CE-marked medical software products in the European Union. Diabetes Tools is privately held and located in Stockholm, Sweden.

About MedHelp
We are experts of Swedish people's wellbeing. Our most important mission is to help people whenever health issues occur. We provide close and personal care with unique competence and availability leading to increased security and better health. Founded in year 2000, today MedHelp is one of the largest private companies providing health care advice at a distance. The annual revenue is approximately 20 M€ (corresponding) and we are around 260 coworkers, most of them nurses. Headquarter is located in Stockholm, Sweden and we're offering an around-the-clock-service.

Most Popular Now

IBM Watson Health Recognizes Top-Perform…

IBM (NYSE: IBM) Watson Health® announced its 2020 Fortune/IBM Watson Health 100 Top Hospitals list and 15 Top Health Systems award winners, naming the top-performing hospitals and health systems in...

Chatbots can Ease Medical Providers' Bur…

COVID-19 has placed tremendous pressure on health care systems, not only for critical care but also from an anxious public looking for answers. Research from the Indiana University Kelley School...

Abbott Receives FDA Approval for New Hea…

Abbott (NYSE: ABT) announced that the U.S. Food and Drug Administration (FDA) has approved the company's next-generation Gallant™ implantable cardioverter defibrillator (ICD) and cardiac resynchronization therapy defibrillator (CRT-D) devices. The...

The New Tattoo: Drawing Electronics on S…

One day, people could monitor their own health conditions by simply picking up a pencil and drawing a bioelectronic device on their skin. In a new study, University of Missouri...

Towards an AI Diagnosis Like the Doctor…

Artificial intelligence (AI) is an important innovation in diagnostics, because it can quickly learn to recognize abnormalities that a doctor would also label as a disease. But the way that...

SARS-CoV-2 Antibody Test from Siemens He…

Public Health England, in partnership with the University of Oxford, recently conducted a head-to-head evaluation of four commercial immunoassay tests available in the UK and used for the detection of...

Researchers Develop Software to Find Dru…

Washington State University researchers have developed an easy-to-use software program to identify drug-resistant genes in bacteria. The program could make it easier to identify the deadly antimicrobial resistant bacteria that...

Philips Introduces First-of-a-Kind Mobil…

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced it introduced first-of-its-kind mobile Intensive Care Units (ICUs) in India. Designed to meet the critical-care requirements...

Proposed Framework for Integrating Chatb…

While the technology for developing artificial intelligence-powered chatbots has existed for some time, a new viewpoint piece in JAMA lays out the clinical, ethical, and legal aspects that must be...

Clinical-Grade Wearables Offer Continuou…

Although it might be tempting to rely on your fitness tracker to catch early signs of COVID-19, Northwestern University researchers caution that consumer wearables are not sophisticated enough to monitor...

World's Smallest Imaging Device has Hear…

A team of researchers led by the University of Adelaide and University of Stuttgart has used 3D micro-printing to develop the world's smallest, flexible scope for looking inside blood vessels...

Optimizing Neural Networks on a Brain-In…

Many computational properties are maximized when the dynamics of a network are at a "critical point", a state where systems can quickly change their overall characteristics in fundamental ways, transitioning...